Vertebral Compression Fracture Devices Market size is predicted to develop substantial growth from 2023 to 2032 due to the high prevalence of spinal compression fractures from trauma and car accidents around the world.
The significance of vertebral compression fracture therapy will increase due to the rising incidence of osteoporosis among the aging population and the rising prevalence of metastatic spinal malignancies. In vertebral compression fractures, the spinal vertebra collapses due to bone compression, causing excruciating pain, deformity, and height loss. This fracture frequently happens in the lower thoracic spine. Many tests, including conventional X-rays, CT scans, and MRIs help diagnose the condition, forecast the prognosis, and narrow down the range of therapy possibilities.
The quick advancements in spine surgery technology are expected to influence the vertebral compression fracture devices market. According to CDC, more than 32.5 million adults in the US have osteoarthritis which may increase the demand for treatment of fractured vertebrae. Since obesity is one of the major risk factors for osteoarthritis, the probable increase in the incidence of bone metastasis in cancer patients along with the rising obese population would further fuel industry expansion.
Geographically, Latin America vertebral compression fracture devices industry will generate high revenue by 2032 as older people are more susceptible to osteoporosis. The growing geriatric population base is what is driving the regional market expansion. Prostate carcinoma metastasis is one of the most prevalent malignancies in nations like Argentina. Such factors will encourage the use of techniques like spine radiology in the years to come. The rising frequency of fractures caused by collisions and accidents and the increasing healthcare spending in Mexico will promote product development over the coming years.
According to procedure type, the market from the vertebroplasty segment is anticipated to generate sizable share by 2032. This procedure is a successful method of treating osteoporotic vertebral compression fractures becoming a popular choice among people. The procedure is substantially less successful in patients suffering from lower lumbar spine fractures than in individuals with higher lumbar fractures.
Vertebral compression fracture devices market from the trauma centers end-use segment is driven by the low death rate of trauma patients treated at these institutions. This has increased demand for spinal compression fractures that undergo therapy at these facilities, influencing product adoption across this sector.
Orthovita, Inc. (Stryker Corporation), Amedica Corporation, Medtronic, DePuy Synthes (Johnson & Johnson), CareFusion Corporation (BD, Cardinal Health), Alphatec Spine, Inc., RTI Surgical (Pioneer Surgical Technology), Cook Medical Inc., Orthofix Interventional, and Biomet Inc. are a few well-known players in the global vertebral compression fracture devices market.